SCHEMBL8797140

SCHEMBL8797140

COC(=O)c1ccc(-c2nc(-c3ccc(N(C)C)cc3)c(-c3ccc(N(C)C)cc3)[nH]2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 1/20 0.67
ALOX5 P09917 5/20 0.66
MAPK14 Q16539 3/20 0.66
MAPK13 O15264 2/20 0.66
MAPK12 P53778 2/20 0.66
MAPK11 Q15759 2/20 0.66
GCGR P47871 1/20 0.66
NOX1 Q9Y5S8 2/20 0.64
IDO1 P14902 1/20 0.57
KDM4E B2RXH2 5/20 0.54
ALDH1A1 P00352 5/20 0.54
HPGD P15428 5/20 0.54
GAA P10253 4/20 0.54
GLA P06280 3/20 0.54
KMT2A Q03164 3/20 0.54
MEN1 O00255 2/20 0.54
CYP1A2 P05177 1/20 0.54
MAPT P10636 1/20 0.54
CYP2C19 P33261 1/20 0.54
GFER P55789 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31742329 0.95 RAF1 (0.76) RAF1ALOX5MAPK14MAPK13MAPK12
SCHEMBL30762099 0.95 RAF1 (0.76) RAF1ALOX5MAPK14MAPK13MAPK12
SCHEMBL8797410 0.86 NOX1 (0.72) RAF1ALOX5MAPK14MAPK13MAPK12
SCHEMBL4552086 0.86 RAF1 (0.88) RAF1ALOX5MAPK14MAPK13MAPK12
SCHEMBL19868984 0.81 MAPK14 (0.81) RAF1ALOX5MAPK14MAPK13MAPK12
SCHEMBL6467424 0.80 NOX1 (0.72) RAF1ALOX5MAPK14MAPK13MAPK12
SCHEMBL8032578 0.80 NOX1 (0.76) RAF1ALOX5MAPK14MAPK13MAPK12
SCHEMBL2649978 0.80 MAPK14 (1.00) RAF1ALOX5MAPK14MAPK13MAPK12
SCHEMBL1071183 0.78 NOX1 (1.00) RAF1ALOX5MAPK14MAPK13MAPK12
SCHEMBL21026201 0.78 ALDH1A1 (0.66) KDM4EALDH1A1HPGDGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812829-A1 Substituted imidazoles as modulators of multi-drug resistance ONTOGEN CORPORATION (US) 1997-12-17 EP disclosed